The greater of two evils? How people with transformative psychotic experiences view psychotropic medications

Ethical Human Psychology and Psychiatry

Volumn 12, Issue 1, 2010, Pages 44-59

  Brad F, Hagen ^a   Gary, Nixon ^a   Tracey, Peters ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL ARTICLE; COGNITIVE DEFECT; CRISIS INTERVENTION; DRUG WITHDRAWAL; EMOTION; EXPERIENCE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEMATOCHEZIA; HUMAN; LETHARGY; MALE; MENTAL HEALTH; NAUSEA; PARESTHESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; QUALITATIVE RESEARCH; RASH; SIDE EFFECT; WEIGHT GAIN;

EID: 77950380255     PISSN: 15594343     EISSN: 19389000     Source Type: Journal    
DOI: 10.1891/1559-4343.12.1.44     Document Type: Article

References (61)

1. Angell, M. (2004). The truth about the drug companies: How they deceive us and what to do about it. New York: Random House.
2. Antonuccio, D. O., Burns, D. D., & Danton, W. G. (2002). Antidepressants: A triumph of marketing over science? Prevention and Treatment, 5, Article 25. Retrieved February 3, 2010, from http://www.journals.apa.org/ prevention/volume5/pre0050025c.html.
3. Awad, A. G., Hogan, T. P., Voruganti, L.N.P., & Heslegrave, R. J. (1995). Patients' subjective experiences on antipsychotic medications: Implications for outcome and quality of life. International Clinical Psychopharmacology, 10(Suppl. 3), 123-132.
4. Barber, C. (2008). Comfortably numb: How psychiatry is medicating a nation. New York: Pantheon.
5. Bassman, R. (2005). Mental illness and the freedom to refuse treatment: Privilege or right. Professional Psychology: Research and Practice, 36(5), 488-497.
6. Bitner, R., Hillman, L., Victor, B., & Walsh, R. (2003). Subjective effects of antidepressants: A pilot study of the varieties of antidepressant-induced experiences in meditators. Journal of Nervous and Mental Disease, 191(10), 660-667.
7. Breeding, J. (2008). To see or not to see "schizophrenia" and the possibility of full "recovery." Journal of Humanistic Psychology, 48(4), 489-504.
8. Breggin, P. R. (1991). Toxic psychiatry. New York: St. Martin's Press.
9. Breggin, P. R., & Cohen, D. (1999). Your drug may be your problem: How and why to stop taking psychiatric medications. Reading, MA: Perseus.
10. Burstow, B., & Weitz, D. (1988). Shrink resistant: The struggle against psychiatry in Canada. Vancouver: New Star Books.
11. Carpenter, W. T., McGlashan, T. H., & Strauss, J. S. (1977). The treatment of acute schizophrenia without drugs: An investigation of some current assumptions. American Journal of Psychiatry, 134(1), 14-20.
12. Cochrane, L. (1986). Portrait and story. Westport, CT: Greenwood Press.
13. Cooper, W., Arbogast, P., Ding, H., Hickson, G., Fuchs, D., & Ray, W. (2006). Trends in prescribing of antipsychotic medications for US children. Ambulatory Pediatrics, 6(2), 79-83.
14. Cornford, C. S., Hill, A., & Reilly, J. (2007). How patients with depressive symptoms view their condition: A qualitative study. Family Practice, 24(4), 358-364.
15. Croghan, T. W. (2001). The controversy of increased spending for antidepressants. Health Affairs, 20(2), 129-135.
16. Everett, B. (2000). A fragile revolution: Consumers and psychiatric survivors confront the power of the mental health system. Waterloo: Wilfrid Laurier University Press.
17. Gelman, S. (1999). Medicating schizophrenia: A history. New Brunswick, NJ: Rutgers University Press.
18. Givens, J., Datto, C., Ruckdeschel, K., Knott, K., Zubritsky, C., Oslin, D., et al. (2005). Older patients' aversion to antidepressants. Journal of General Internal Medicine, 21(2), 146-151.
19. Glenmullen, J. (2000). Prozac backlash: Overcoming the dangers of Prozac, Zoloft, Paxil, and other antidepressants with safe, effective alternatives. New York: Simon & Schuster.
20. Gray, R., Rofail, D., Allen, J., & Newey, T. (2004). A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. Journal of Advanced Nursing, 52(1), 31-37. (Pubitemid 41316763)
21. Grof, S., & Grof, C. (1989). Spiritual emergency: When personal transformation becomes a crisis. New York: Tarcher Putnam.
22. Happell, B., Manias, E., & Roper, C. (2004). Wanting to be heard: Mental health consumers' experiences of information about medication. International Journal of Mental Health Nursing, 13(4), 242-248.
23. Healy, D. (2002). The creation of psychopharmacology. Cambridge, MA: Harvard University Press.
24. Heidegger, M. (1996). Being and time: A translation of Sein and Zeit. Albany: State University of New York Press.
25. Jackson, G. E. (2005). Rethinking psychiatric drugs: A guide for informed consent. Bloomington, IN: Authorhouse.
26. Jureidini, J., & Tonkin, A. (2006). Overuse of antidepressant drugs for the treatment of depression. CNS Drugs, 20(8), 623-632.
27. Karp, D. A. (1993). Taking anti-depressant medications: Resistance, trial commitment, conversion, disenchantment. Qualitative Sociology, 16(4), 337-359.
28. Kessing, L. V., Hansen, H. V., Demyttenaere, K., & Bech, P. (2005). Depressive and bipolar disorders: Patients' attitudes and beliefs towards depression and antidepressants. Psychological Medicine, 35(8), 1205-1213.
29. Kilian, R., Lindenbach, I., Lobig, U., Uhle, M., Petscheleit, A., & Angermeyer, C. (2003). Indicators of empowerment and disempowerment in the subjective evaluation of the psychiatric treatment process by persons with severe and persistent mental illness: A qualitative and quantitative analysis. Social Science and Medicine, 57(6), 1127-1142.
30. Knudsen, P., Hansen, E. H., & Eskildsen, K. (2003). Leading ordinary lives: A qualitative study of younger women's perceived functions of antidepressants. Pharmacy World and Science, 25(4), 162-167.
31. Knudsen, P., Hansen, E. H., Traulsen, J. M., & Eskildsen, K. (2002). Changes in self-concept while using SSRI antidepressants. Qualitative Health Research, 12(7), 932-944.
32. Kwintner, M. (2005). Message in a bottle: The meanings of antidepressant medication for psychotherapy patients. Smith College Studies in Social Work, 75(2), 27-52.
33. Malpass, A., Shaw, A., Sharp, D., Walter, F., Feder, G., Ridd, M., et al. (2009). "Medication career" or "moral career"? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressants. Social Science and Medicine, 68, 154-168.
34. Marder, S. R., Swann, E., Winslade, W. J., Van Putten, T., Chien, C. P., & Wilkins, J. N. (1984). A study of medication refusal by involuntary psychiatric patients. Hospital and Community Psychiatry, 35, 724-726.
35. Marder, S. R., van Kammen, D. P., Docherty, J. P., Rayner, J., & Bunney, W. E. (1979). Predicting drug-free improvement in schizophrenic psychosis. General Psychiatry, 36, 1080-1085.
36. McGlashan, T. (2006). Rationale and parameters for medication-free research in psychosis. Schizophrenia Bulletin, 32(2), 300-302.
37. Modrow, J. (2003). How to become a schizophrenic: The case against biological psychiatry. New York: Writers Club Press.
38. Moynihan, R., & Cassels, A. (2005). A disease for every pill. Nation, 281, 22-25.
39. Naber, D. (2005). Subjective effects of antipsychotic treatment. Acta Psychiatry Scandinavia, 111(2), 81-83.
40. Nelson, J. E. (1994). Healing the split: Integrating spirit into our understanding of the mentally ill. New York: State University of New York Press.
41. Nixon, G., Hagen, B., & Peters, T. (2009). Psychosis and transformation: A phenomenological inquiry. International Journal of Mental Health and Addictions, doi: 10.1007/s11469-009-9231-3.
42. Nixon, G., Hagen, B., & Peters, T. (2010). Recovery from psychosis: A phenomenological inquiry. Manuscript submitted for publication.
43. Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41(5), 514-521.
44. Osborne, J. (1990). Some basic existential phenomenological research methodology for counsellors. Canadian Journal of Counselling, 24(2), 79-91.
45. Paulose-Ram, R., Jonas, B. S., Orwig, D., & Safran, M. A. (2004). Prescription psychotropic medication use among the U.S. adult population: Results from the third national health and nutrition examination survey, 1988-1994. Journal of Clinical Epidemiology, 57(3), 309-317.
46. Paulose-Ram, R., Safran, M. A., Jonas, B. S., Gu, Q., & Orwig, D. (2007). Trends in psychotropic medication use among U.S. Adults. Pharmacoepidemiology and Drug Safety, 16(5), 560-570.
47. Perry, J. W. (1999). Trials of the visionary mind: Spiritual emergency and the renewal process. New York: State University of New York Press.
48. Perry, J. W. (2005). The far side of madness. Putnam: Spring Publications.
49. Pestello, F. G., & Davis-Berman, J. (2008). Taking anti-depressant medication: A qualitative examination of internet postings. Journal of Mental Health, 17(4), 349-360.
50. Pollock, K., Grime, J., Barker, E., & Mantala, K. (2004). Meeting the information needs of psychiatric inpatients: Staff and patient perspective. Journal of Mental Health, 13(4), 389-401.
51. Rappaport, M., Hopkins, H. K., Hall, K., Belleza, T., & Silverman, J. (1978). Are there schizophrenics for whom drugs may be unnecessary or contraindicated? International Pharmacopsychiatry, 13(2), 100-111.
52. Read, J., Mosher, L. R., & Bentall, R. P. (2004). Models of madness: Psychological, social and biological approaches to schizophrenia. Hove: Brunner/ Routledge.
53. Rettenbacher, M. A., Burns, T., Kemmler, G., & Fleischhacker, W. W. (2004). Schizophrenia: Attitudes of patients and professional carers towards the illness and antipsychotic medication. Pharmacopsychiatry, 37(3), 103-109.
54. Turner, K. M., Sharp, D., Folkes, L., & Chew-Graham, C. (2008). Women's views and experiences of antidepressants as a treatment for postnatal depression: A qualitative study. Family Practice, 25(6), 450-455.
55. Usher, K. (2001). Taking neuroleptic medications as the treatment for schizophrenia: A phenomenological study. Australian and New Zealand Journal of Mental Health Nursing, 10(3), 145-155.
56. Valenstein, E. S. (1998). Blaming the brain. New York: Free Press.
57. Van Manen, M. (1990). Researching lived experience: Human sciences for an action sensitive pedagogy. London, ON: Althouse Press.
58. Van Voorhees, B., Fogel, J., Houston, T., Cooper, L., Wang, N., & Ford, D. (2005). Beliefs and attitudes associate with the intention to not accept the diagnosis of depression among young adults. Annals of Family Medicine, 3(1), 38-46.
59. Verbeek-Heida, P. M., & Mathot, E. F. (2006). Better safe than sorry -Why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: Results of a qualitative study. Chronic Illness, 2(2), 133-142.
60. Volkman, A., & Stastny, P. (2007). Full disclosure: Toward a participatory and risk-limiting approach to neuroleptic drugs. Ethical Human Psychology and Psychiatry, 9(1), 35-61.
61. Whitaker, R. (2002). Mad in America: Bad science, bad medicine, and the enduring mistreatment of the mentally ill. Cambridge: Perseus.